N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects.
Simon
K
K
Szépvölgyi
A
A
D000111:Acetylcysteine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D005996:Nitroglycerin / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D016166:Free Radical Scavengers; D014665:Vasodilator Agents; D013300:Streptokinase; D005996:Nitroglycerin; D000111:Acetylcysteine